{"id":26528,"date":"2021-05-19T15:14:37","date_gmt":"2021-05-19T14:14:37","guid":{"rendered":"https:\/\/faus-moliner.com\/?p=26528"},"modified":"2021-05-19T15:33:30","modified_gmt":"2021-05-19T14:33:30","slug":"faus-moliner-at-the-eu-pharmaceutical-law-forum","status":"publish","type":"post","link":"https:\/\/faus-moliner.com\/en\/faus-moliner-at-the-eu-pharmaceutical-law-forum\/","title":{"rendered":"Faus &#038; Moliner at the EU Pharmaceutical Law Forum"},"content":{"rendered":"\n<p>In its 30th edition, the EU Pharmaceutical Law Forum has offered an in-depth analysis of the hottest topics affecting pharmaceutical and life sciences companies with the participation of the most relevant professionals in the field of pharmaceutical law from all over Europe.<\/p>\n\n\n\n<p>Jordi Faus has participated in the Seminar \u00abMarket Access for Innovative Therapies\u00bb, along with Christian Jervelund (Managing Partner at Copenhagen Economics) Marieke Jansen (Head Legal Cell and Gene Europe, Novartis), Adela Williams and Alexander Roussanov (partners, Arnold &amp; Porter), where he has offered a presentation on innovative payment models and structuring contracts. In his presentation, Jordi has spoken about the legal challenges raised by the need to improve access to innovative therapies whilst ensuring sutainability; and also about the structural challenges faced by payors and public healthcare providers.<\/p>\n\n\n\n<p>Jordi Faus has also moderated the Interactive discussion on Regulatory Flexibility, where the speakers have been Sandra Vanlievendael, (Head of Pharmaceutical Law at the European Medicines Agency) , Virginia Acha (Associate Vice President, Global Regulatory Policy, MSD) and Eveline Van Keymeulen (Partner at Latham &amp; Watkins). In this session, the speakers have had the opportunity to discuss about lessons learned from COVID-19 and how to convert these to \u201cfit for innovation\u201d regulation, about new initiatives including rolling reviews and adapted approaches to regulatory assessments; and about how regulations may help to respond to future emergency situations.<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"627\" src=\"https:\/\/faus-moliner.com\/wp-content\/uploads\/2021\/05\/EU-Pharmaceutical-Law-Forum-2021-1024x627.png\" alt=\"\" class=\"wp-image-26529\" srcset=\"https:\/\/faus-moliner.com\/wp-content\/uploads\/2021\/05\/EU-Pharmaceutical-Law-Forum-2021-1024x627.png 1024w, https:\/\/faus-moliner.com\/wp-content\/uploads\/2021\/05\/EU-Pharmaceutical-Law-Forum-2021-300x184.png 300w, https:\/\/faus-moliner.com\/wp-content\/uploads\/2021\/05\/EU-Pharmaceutical-Law-Forum-2021-29x18.png 29w, https:\/\/faus-moliner.com\/wp-content\/uploads\/2021\/05\/EU-Pharmaceutical-Law-Forum-2021-768x470.png 768w, https:\/\/faus-moliner.com\/wp-content\/uploads\/2021\/05\/EU-Pharmaceutical-Law-Forum-2021.png 1036w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n","protected":false},"excerpt":{"rendered":"<p>In its 30th edition, the EU Pharmaceutical Law Forum has offered an in-depth analysis of the hottest topics affecting pharmaceutical and life sciences companies with the participation of the most relevant professionals in the field of pharmaceutical law from all over Europe. Jordi Faus has participated in the Seminar \u00abMarket Access for Innovative Therapies\u00bb, along&#8230; <\/p>\n<div class=\"clear\"><\/div>\n<p><a href=\"https:\/\/faus-moliner.com\/en\/faus-moliner-at-the-eu-pharmaceutical-law-forum\/\" class=\"excerpt-read-more\">Read More<\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[209],"tags":[],"coauthors":[],"class_list":["post-26528","post","type-post","status-publish","format-standard","hentry","category-news-events"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.6 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Faus &amp; Moliner at the EU Pharmaceutical Law Forum - Faus Moliner<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/faus-moliner.com\/en\/faus-moliner-at-the-eu-pharmaceutical-law-forum\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Faus &amp; Moliner at the EU Pharmaceutical Law Forum - Faus Moliner\" \/>\n<meta property=\"og:description\" content=\"In its 30th edition, the EU Pharmaceutical Law Forum has offered an in-depth analysis of the hottest topics affecting pharmaceutical and life sciences companies with the participation of the most relevant professionals in the field of pharmaceutical law from all over Europe. Jordi Faus has participated in the Seminar \u00abMarket Access for Innovative Therapies\u00bb, along... Read More\" \/>\n<meta property=\"og:url\" content=\"https:\/\/faus-moliner.com\/en\/faus-moliner-at-the-eu-pharmaceutical-law-forum\/\" \/>\n<meta property=\"og:site_name\" content=\"Faus Moliner\" \/>\n<meta property=\"article:published_time\" content=\"2021-05-19T14:14:37+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-05-19T14:33:30+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/faus-moliner.com\/wp-content\/uploads\/2021\/05\/EU-Pharmaceutical-Law-Forum-2021-1024x627.png\" \/>\n<meta name=\"author\" content=\"Faus Moliner\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Faus Moliner\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/faus-moliner.com\/en\/faus-moliner-at-the-eu-pharmaceutical-law-forum\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/faus-moliner.com\/en\/faus-moliner-at-the-eu-pharmaceutical-law-forum\/\"},\"author\":{\"name\":\"Faus Moliner\",\"@id\":\"https:\/\/faus-moliner.com\/en\/#\/schema\/person\/b62ac2c67efed1b6f50872c1d6366f90\"},\"headline\":\"Faus &#038; Moliner at the EU Pharmaceutical Law Forum\",\"datePublished\":\"2021-05-19T14:14:37+00:00\",\"dateModified\":\"2021-05-19T14:33:30+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/faus-moliner.com\/en\/faus-moliner-at-the-eu-pharmaceutical-law-forum\/\"},\"wordCount\":233,\"publisher\":{\"@id\":\"https:\/\/faus-moliner.com\/en\/#organization\"},\"image\":{\"@id\":\"https:\/\/faus-moliner.com\/en\/faus-moliner-at-the-eu-pharmaceutical-law-forum\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/faus-moliner.com\/wp-content\/uploads\/2021\/05\/EU-Pharmaceutical-Law-Forum-2021-1024x627.png\",\"articleSection\":[\"News &amp; Events\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/faus-moliner.com\/en\/faus-moliner-at-the-eu-pharmaceutical-law-forum\/\",\"url\":\"https:\/\/faus-moliner.com\/en\/faus-moliner-at-the-eu-pharmaceutical-law-forum\/\",\"name\":\"Faus & Moliner at the EU Pharmaceutical Law Forum - Faus Moliner\",\"isPartOf\":{\"@id\":\"https:\/\/faus-moliner.com\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/faus-moliner.com\/en\/faus-moliner-at-the-eu-pharmaceutical-law-forum\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/faus-moliner.com\/en\/faus-moliner-at-the-eu-pharmaceutical-law-forum\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/faus-moliner.com\/wp-content\/uploads\/2021\/05\/EU-Pharmaceutical-Law-Forum-2021-1024x627.png\",\"datePublished\":\"2021-05-19T14:14:37+00:00\",\"dateModified\":\"2021-05-19T14:33:30+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/faus-moliner.com\/en\/faus-moliner-at-the-eu-pharmaceutical-law-forum\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/faus-moliner.com\/en\/faus-moliner-at-the-eu-pharmaceutical-law-forum\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/faus-moliner.com\/en\/faus-moliner-at-the-eu-pharmaceutical-law-forum\/#primaryimage\",\"url\":\"https:\/\/faus-moliner.com\/wp-content\/uploads\/2021\/05\/EU-Pharmaceutical-Law-Forum-2021-1024x627.png\",\"contentUrl\":\"https:\/\/faus-moliner.com\/wp-content\/uploads\/2021\/05\/EU-Pharmaceutical-Law-Forum-2021-1024x627.png\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/faus-moliner.com\/en\/faus-moliner-at-the-eu-pharmaceutical-law-forum\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\/\/faus-moliner.com\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Faus &#038; Moliner at the EU Pharmaceutical Law Forum\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/faus-moliner.com\/en\/#website\",\"url\":\"https:\/\/faus-moliner.com\/en\/\",\"name\":\"faus-moliner.com\",\"description\":\"Otro sitio realizado con WordPress\",\"publisher\":{\"@id\":\"https:\/\/faus-moliner.com\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/faus-moliner.com\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/faus-moliner.com\/en\/#organization\",\"name\":\"Faus Moliner\",\"url\":\"https:\/\/faus-moliner.com\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/faus-moliner.com\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/faus-moliner.com\/wp-content\/uploads\/2023\/03\/Logo-FM-web.jpg\",\"contentUrl\":\"https:\/\/faus-moliner.com\/wp-content\/uploads\/2023\/03\/Logo-FM-web.jpg\",\"width\":400,\"height\":283,\"caption\":\"Faus Moliner\"},\"image\":{\"@id\":\"https:\/\/faus-moliner.com\/en\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.linkedin.com\/company\/2372042\/admin\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/faus-moliner.com\/en\/#\/schema\/person\/b62ac2c67efed1b6f50872c1d6366f90\",\"name\":\"Faus Moliner\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/faus-moliner.com\/en\/#\/schema\/person\/image\/88610ef99b0aa1c93ca33c569a053dac\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/be7b0f78e7edd64676ce7ea245b31f149a0cffff4b139c25ac02aaa676c19d67?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/be7b0f78e7edd64676ce7ea245b31f149a0cffff4b139c25ac02aaa676c19d67?s=96&d=mm&r=g\",\"caption\":\"Faus Moliner\"},\"url\":\"https:\/\/faus-moliner.com\/en\/author\/moon\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Faus & Moliner at the EU Pharmaceutical Law Forum - Faus Moliner","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/faus-moliner.com\/en\/faus-moliner-at-the-eu-pharmaceutical-law-forum\/","og_locale":"en_US","og_type":"article","og_title":"Faus & Moliner at the EU Pharmaceutical Law Forum - Faus Moliner","og_description":"In its 30th edition, the EU Pharmaceutical Law Forum has offered an in-depth analysis of the hottest topics affecting pharmaceutical and life sciences companies with the participation of the most relevant professionals in the field of pharmaceutical law from all over Europe. Jordi Faus has participated in the Seminar \u00abMarket Access for Innovative Therapies\u00bb, along... Read More","og_url":"https:\/\/faus-moliner.com\/en\/faus-moliner-at-the-eu-pharmaceutical-law-forum\/","og_site_name":"Faus Moliner","article_published_time":"2021-05-19T14:14:37+00:00","article_modified_time":"2021-05-19T14:33:30+00:00","og_image":[{"url":"https:\/\/faus-moliner.com\/wp-content\/uploads\/2021\/05\/EU-Pharmaceutical-Law-Forum-2021-1024x627.png","type":"","width":"","height":""}],"author":"Faus Moliner","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Faus Moliner","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/faus-moliner.com\/en\/faus-moliner-at-the-eu-pharmaceutical-law-forum\/#article","isPartOf":{"@id":"https:\/\/faus-moliner.com\/en\/faus-moliner-at-the-eu-pharmaceutical-law-forum\/"},"author":{"name":"Faus Moliner","@id":"https:\/\/faus-moliner.com\/en\/#\/schema\/person\/b62ac2c67efed1b6f50872c1d6366f90"},"headline":"Faus &#038; Moliner at the EU Pharmaceutical Law Forum","datePublished":"2021-05-19T14:14:37+00:00","dateModified":"2021-05-19T14:33:30+00:00","mainEntityOfPage":{"@id":"https:\/\/faus-moliner.com\/en\/faus-moliner-at-the-eu-pharmaceutical-law-forum\/"},"wordCount":233,"publisher":{"@id":"https:\/\/faus-moliner.com\/en\/#organization"},"image":{"@id":"https:\/\/faus-moliner.com\/en\/faus-moliner-at-the-eu-pharmaceutical-law-forum\/#primaryimage"},"thumbnailUrl":"https:\/\/faus-moliner.com\/wp-content\/uploads\/2021\/05\/EU-Pharmaceutical-Law-Forum-2021-1024x627.png","articleSection":["News &amp; Events"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/faus-moliner.com\/en\/faus-moliner-at-the-eu-pharmaceutical-law-forum\/","url":"https:\/\/faus-moliner.com\/en\/faus-moliner-at-the-eu-pharmaceutical-law-forum\/","name":"Faus & Moliner at the EU Pharmaceutical Law Forum - Faus Moliner","isPartOf":{"@id":"https:\/\/faus-moliner.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/faus-moliner.com\/en\/faus-moliner-at-the-eu-pharmaceutical-law-forum\/#primaryimage"},"image":{"@id":"https:\/\/faus-moliner.com\/en\/faus-moliner-at-the-eu-pharmaceutical-law-forum\/#primaryimage"},"thumbnailUrl":"https:\/\/faus-moliner.com\/wp-content\/uploads\/2021\/05\/EU-Pharmaceutical-Law-Forum-2021-1024x627.png","datePublished":"2021-05-19T14:14:37+00:00","dateModified":"2021-05-19T14:33:30+00:00","breadcrumb":{"@id":"https:\/\/faus-moliner.com\/en\/faus-moliner-at-the-eu-pharmaceutical-law-forum\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/faus-moliner.com\/en\/faus-moliner-at-the-eu-pharmaceutical-law-forum\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/faus-moliner.com\/en\/faus-moliner-at-the-eu-pharmaceutical-law-forum\/#primaryimage","url":"https:\/\/faus-moliner.com\/wp-content\/uploads\/2021\/05\/EU-Pharmaceutical-Law-Forum-2021-1024x627.png","contentUrl":"https:\/\/faus-moliner.com\/wp-content\/uploads\/2021\/05\/EU-Pharmaceutical-Law-Forum-2021-1024x627.png"},{"@type":"BreadcrumbList","@id":"https:\/\/faus-moliner.com\/en\/faus-moliner-at-the-eu-pharmaceutical-law-forum\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/faus-moliner.com\/en\/"},{"@type":"ListItem","position":2,"name":"Faus &#038; Moliner at the EU Pharmaceutical Law Forum"}]},{"@type":"WebSite","@id":"https:\/\/faus-moliner.com\/en\/#website","url":"https:\/\/faus-moliner.com\/en\/","name":"faus-moliner.com","description":"Otro sitio realizado con WordPress","publisher":{"@id":"https:\/\/faus-moliner.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/faus-moliner.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/faus-moliner.com\/en\/#organization","name":"Faus Moliner","url":"https:\/\/faus-moliner.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/faus-moliner.com\/en\/#\/schema\/logo\/image\/","url":"https:\/\/faus-moliner.com\/wp-content\/uploads\/2023\/03\/Logo-FM-web.jpg","contentUrl":"https:\/\/faus-moliner.com\/wp-content\/uploads\/2023\/03\/Logo-FM-web.jpg","width":400,"height":283,"caption":"Faus Moliner"},"image":{"@id":"https:\/\/faus-moliner.com\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/2372042\/admin\/"]},{"@type":"Person","@id":"https:\/\/faus-moliner.com\/en\/#\/schema\/person\/b62ac2c67efed1b6f50872c1d6366f90","name":"Faus Moliner","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/faus-moliner.com\/en\/#\/schema\/person\/image\/88610ef99b0aa1c93ca33c569a053dac","url":"https:\/\/secure.gravatar.com\/avatar\/be7b0f78e7edd64676ce7ea245b31f149a0cffff4b139c25ac02aaa676c19d67?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/be7b0f78e7edd64676ce7ea245b31f149a0cffff4b139c25ac02aaa676c19d67?s=96&d=mm&r=g","caption":"Faus Moliner"},"url":"https:\/\/faus-moliner.com\/en\/author\/moon\/"}]}},"_links":{"self":[{"href":"https:\/\/faus-moliner.com\/en\/wp-json\/wp\/v2\/posts\/26528","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/faus-moliner.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/faus-moliner.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/faus-moliner.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/faus-moliner.com\/en\/wp-json\/wp\/v2\/comments?post=26528"}],"version-history":[{"count":10,"href":"https:\/\/faus-moliner.com\/en\/wp-json\/wp\/v2\/posts\/26528\/revisions"}],"predecessor-version":[{"id":26649,"href":"https:\/\/faus-moliner.com\/en\/wp-json\/wp\/v2\/posts\/26528\/revisions\/26649"}],"wp:attachment":[{"href":"https:\/\/faus-moliner.com\/en\/wp-json\/wp\/v2\/media?parent=26528"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/faus-moliner.com\/en\/wp-json\/wp\/v2\/categories?post=26528"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/faus-moliner.com\/en\/wp-json\/wp\/v2\/tags?post=26528"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/faus-moliner.com\/en\/wp-json\/wp\/v2\/coauthors?post=26528"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}